UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022476
Receipt number R000025899
Scientific Title The efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema
Date of disclosure of the study information 2016/05/26
Last modified on 2020/08/23 11:49:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema

Acronym

The efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema

Scientific Title

The efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema

Scientific Title:Acronym

The efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema

Region

Japan


Condition

Condition

Diabetic macula edema

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of the treat and extend protocol with Aflibercept for diabetic macula edema.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Visual acuity,central retinal thickness (CRT) measured on optical coherence tomography (OCT)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Aflibercept will be administered by intravitreal injection at a dose of 2mg (0.05 mL) at intervals of at least 1 month.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with type 1 or type 2 diabetes mellitus 20 years of age or older
2.Patients with fovea involving diabetic macular edema
3.Patients with reduced visual acuity associated with diabetic macular edema
4.Patients whose best corrected visual acuity is less than or equal to 6/10
5.Patients with a central retinal thickness (CRT) of 300 um or more on the OCT

Key exclusion criteria

1.A history of vitreous surgery, including encircling buckling
2.Any retinal photocoagulation treatment or treatment with injection of any anti VEGF agent within 90 days
3.Highly active, proliferative diabetic retinopathy
4.A history of ocular inflammation
5.A history of any intraocular surgery within the previous 90 days
6.Aphakic eyes
7.Contrast medium allergy
8.It is considered difficult to improve visual acuity due to morphological changes
9.Glaucoma with poor IOP control,or IOP of the study eye: more than 25 mmHg
10.Myopia of -8D or greater
11.Severe systemic infections
12.Treatment with carcinostatic agent
13.Uncontrolled diabetes mellitus,as defined by HbA1c >12%
14.Uncontrolled blood pressure,defined as systolic >180 mmHg or diastolic >100 mmHg while subject is sitting)
15.A history of cerebrovascular accident and/or myocardial infarction within 180 days
16.Patients on dialysis and patients with renal failure requiring transplantation
17.Pregant or lactating

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Chie Sotozono

Organization

Kyoto Prefecture University of Medicine

Division name

Depertment of ophthalmology

Zip code


Address

465 Kajiityo,Kyoto,Japan

TEL

0752515578

Email

csotozon@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroki Mieno

Organization

Kyoto Prefecture University of Medicine

Division name

Depertment of ophthalmology

Zip code


Address

465 Kajiityo,Kyoto,Japan

TEL

0752515578

Homepage URL


Email

hmieno@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefecture University of Medicine
Depertment of ophthalmology

Institute

Department

Personal name



Funding Source

Organization

Bayer HealthCare

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 05 Day

Date of IRB

2015 Year 03 Month 05 Day

Anticipated trial start date

2015 Year 03 Month 25 Day

Last follow-up date

2018 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 05 Month 26 Day

Last modified on

2020 Year 08 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025899


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name